In crypto, real gains don’t happen when the spotlight is at full strength. They happen in the quiet moments, when something with massive potential is just begin ...

Privacy is no longer optional, it’s a necessity. With regulators intensifying their oversight and data breaches making ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

A Python visualizer is a tool that shows you how your code runs, step by step, using pictures and diagrams. It helps you see ...

In crypto, real fortunes are made not when everyone is piling in but when something powerful is just beginning to move. Right ...

Reverse automation describes how technology is creating new human-centered jobs in the spaces where machines fall short, ...

Deemos Tech, a leading 3D generative AI company, today announced the landmark launch of Hyper3D Rodin Gen-2, its ...

Psy makes web2 business models financially viable on web3, with applications from commerce to agentic AI.

Alan Turing and John von Neumann saw it early: the logic of life and the logic of code may be one and the same.

My parents sat through a breathless monologue on one of the most exhausting systems USC has to offer: general education. An interlocking web of requirements and rules guards our diplomas with a ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...